|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 5/0783 | |
| A61K 35/50 | |||
| A61P 35/00 | |||
| A61K 35/12 |
| (11) | Number of the document | 2411506 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10722830.6 |
| Date of filing the European patent application | 2010-03-26 | |
| (97) | Date of publication of the European application | 2012-02-01 |
| (45) | Date of publication and mention of the grant of the patent | 2018-11-07 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2010/028885 |
| Date | 2010-03-26 |
| (87) | Number | WO 2010/111631 |
| Date | 2010-09-30 |
| (30) | Number | Date | Country code |
| 163449 P | 2009-03-25 | US |
| (72) |
ZHANG, Xiaokui, US
KANG, Lin, US
HEIDARAN, Mohammad, US
JASKO, Steven, US
ZEITLIN, Andy, US
PAL, Ajai, US
HARIRI, Robert, J., US
|
| (73) |
Celularity, Inc.,
33 Technology Drive, Warren, NJ 07059,
US
|
| (54) | TUMOR SUPPRESSION USING HUMAN PLACENTA-DERIVED INTERMEDIATE NATURAL KILLER CELLS AND IMMUNOMODULATORY COMPOUNDS |
| TUMOR SUPPRESSION USING HUMAN PLACENTA-DERIVED INTERMEDIATE NATURAL KILLER CELLS AND IMMUNOMODULATORY COMPOUNDS |